Back
Amneal Pharmaceuticals, Inc. Vs. Carter's, Inc. Industry Stock Comparison
Sell
44
AMRX
Amneal Pharmaceuticals, Inc.
Last Price:
$12.48
Seasonality Move:
10.64%
Buy
55
CRI
Carter's, Inc.
Last Price:
$35.86
Seasonality Move:
1.9%
Sell
44
Amneal Pharmaceuticals, Inc. (AMRX)
is a Sell
Is Amneal Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Amneal Pharmaceuticals, Inc. [AMRX] share price is $12.48. The Score for AMRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
AMRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Carter's, Inc. (CRI)
is a Buy
Is Carter's, Inc. a Buy, Sell or Hold?
-
The current Carter's, Inc. [CRI] share price is $35.91. The Score for CRI is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
CRI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AMRX Stock Price Chart
What is Amneal Pharmaceuticals, Inc.'s stock price today?
-
The Amneal Pharmaceuticals, Inc. share price today is $12.48Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMRX is experiencing slight buying pressure.
CRI Stock Price Chart
What is Carter's, Inc.'s stock price today?
-
The Carter's, Inc. share price today is $35.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRI is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 46.62 | Sell |
| Chaikin Money Flow: | 34646 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.95 - 13.21) | Sell |
| Bollinger Bands (100): | (11.96 - 13.94) | Sell |
CRI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 52.47 | Buy |
| Chaikin Money Flow: | 415895 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.1 - 35.4) | Buy |
| Bollinger Bands (100): | (31.49 - 37.79) | Buy |
AMRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.23 | Buy |
| 20-day SMA: | 12.36 | Buy |
| 50-day SMA: | 13.47 | Sell |
| 200-day SMA: | 11.12 | Buy |
| 8-day EMA: | 12.32 | Buy |
| 20-day EMA: | 12.52 | Sell |
| 50-day EMA: | 12.91 | Sell |
| 200-day EMA: | 11.5 | Buy |
CRI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.13 | Buy |
| 20-day SMA: | 34.69 | Buy |
| 50-day SMA: | 36.57 | Sell |
| 200-day SMA: | 31.99 | Buy |
| 8-day EMA: | 35.28 | Buy |
| 20-day EMA: | 35.36 | Buy |
| 50-day EMA: | 35.61 | Buy |
| 200-day EMA: | 35.4 | Buy |
Amneal Pharmaceuticals, Inc. Earnings Growth & AMRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.19 per share, and an increase next year of $0.19 per share.
Carter's, Inc. Earnings Growth & CRI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.70 per share, a decrease this year of $0.22 per share, and an increase next year of $0.50 per share.
Amneal Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Carter's, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||